ArticleAmerican journal of cancer research2026
Targeting Osteoclastogenesis: Sabutoclax reduces tumor-associated osteolysis and tumor burden within the bone microenvironment.
Liang Liao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.